ArticleHaematologica2023

Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial.

Thomas Schroeder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.